Follow-up: Why we hide unevidenced fraud accusations and log the hiding

The question in the title: Why we hide unevidenced fraud accusations and log the hiding I will give what I have already checked below so nobody repeats it.

Structured report rather than an opinion, following the format the maintainers asked for.

• Compound: retatrutide
• Independent testing: PeptideMeter
• Method as reported: reversed-phase HPLC, 280 nm
• Result: 97.5% area
• Certificate figure for the same lot: 98%

I am not drawing a conclusion about the supplier from one lot and I would ask that nobody else does either. I am adding a data point to a record.

Picking up the opening post: that is the part I would want checked first.

Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you something about systems behind the document. A certificate that is a number and a signature tells you less.

On the opening post — agreed on the reasoning, with one qualification.

Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth documenting.

Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and legitimacy.

Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming implausible perfection without backing evidence is overreaching.

Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices without justification raise different flags.

Worth separating two things that post #3 runs together.

Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same product, is a red flag for either incompetence or deception.

post #7 is right about the mechanism and I think understates the practical bit.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.

Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not glamorous but it is foundational.

post #12 answers the question as asked. The question underneath it is different.

Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.

On post #10 — agreed on the reasoning, with one qualification.

Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong strength, or wrong batch on the label), and failure to provide documentation when asked.